Smith & Nephew 

M$256.55
547
+M$12.77+5.24% Friday 16:36

Statistics

Day High
256.55
Day Low
256.55
52W High
256.55
52W Low
243.78
Volume
0
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.87%
Dividend
7.36

Upcoming

Dividends

2.87%Dividend Yield
Nov 25
M$2.79
May 25
M$4.7
Nov 24
M$2.81
May 24
M$3.86
Nov 23
M$2.63
10Y Growth
2.54%
5Y Growth
-0.65%
3Y Growth
2.95%
1Y Growth
N/A

Earnings

2MarExpected
Q2 2024
Q4 2024
Q2 2025
Next
7.11
8.16
9.2
10.25
Expected EPS
10.24840955629
Actual EPS
N/A

Financials

7.06%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
114.03BRevenue
8.05BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SN1N.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a direct competitor, offering a similar range of orthopedic and medical devices.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc specializes in medical technologies, services, and solutions, including those for surgical devices, competing in areas overlapping with Smith & Nephew.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the manufacture of musculoskeletal healthcare products, directly overlapping with Smith & Nephew's product lines.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the medical devices sector through its subsidiary DePuy Synthes, which competes in orthopedics, a key area for Smith & Nephew.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes with Smith & Nephew in the medical devices market, particularly in areas of advanced surgical and wound care products.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, competing with Smith & Nephew's advanced surgical technologies.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes in various healthcare segments, including medical devices that overlap with Smith & Nephew's portfolio.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a broad range of hospital and surgical products, competing in the medical supplies and devices sector.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. is a spine and orthopedics-focused company, directly competing with Smith & Nephew in the orthopedic surgery market.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation specializes in heart and critical care products, competing indirectly in the medical devices market.

About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Show more...
CEO
ISIN
GB0009223206

Listings

0 Comments

Share your thoughts

FAQ

What is Smith & Nephew stock price today?
The current price of SN1N.MX is M$256.55 MXN — it has increased by +5.24% in the past 24 hours. Watch Smith & Nephew stock price performance more closely on the chart.
What is Smith & Nephew stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Smith & Nephew stocks are traded under the ticker SN1N.MX.
Is Smith & Nephew stock price growing?
SN1N.MX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Smith & Nephew has showed a +5.24% increase.
When is the next Smith & Nephew earnings date?
Smith & Nephew is going to release the next earnings report on March 02, 2026.
What were Smith & Nephew earnings last quarter?
SN1N.MX earnings for the last quarter are 8.03 MXN per share, whereas the estimation was 7.4 MXN resulting in a +8.6% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Smith & Nephew revenue for the last year?
Smith & Nephew revenue for the last year amounts to 114.03B MXN.
What is Smith & Nephew net income for the last year?
SN1N.MX net income for the last year is 8.05B MXN.
Does Smith & Nephew pay dividends?
Yes, SN1N.MX dividends are paid semi-annual. The last dividend per share was 2.79 MXN. As of today, Dividend Yield (FWD)% is 2.87%.
When did Smith & Nephew complete a stock split?
Smith & Nephew has not had any recent stock splits.